Dosimetry-Based Consideration on Remission and Relapse after Therapy with (223)Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case Report

Here, we present the case of a 64-year-old male patient diagnosed with castration-resistant prostate cancer (CRPC) with bone metastasis, treated with abiraterone prednisone/prednisolone in combination with (223)Ra-dichloride therapy, who had remission and a subsequent relapse of bone metastasis on r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangano, Anna Maria, Pacilio, Massimiliano, Ialongo, Pasquale, Semprebene, Alessandro, Ventroni, Guido, Mango, Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872001/
https://www.ncbi.nlm.nih.gov/pubmed/29495541
http://dx.doi.org/10.3390/diagnostics8010018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872001/
https://www.ncbi.nlm.nih.gov/pubmed/29495541
http://dx.doi.org/10.3390/diagnostics8010018

Ejemplares similares